✦ LIBER ✦

Palliative care and induction therapy: a complimentary approach to the treatment of acute myeloid leukemia

✍ Scribed by Mary Laudon Thomas

Book ID: 114118975
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 60 KB
Volume: 25
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(01)00009-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Integrated Genomic Approach to the As

An Integrated Genomic Approach to the Assessment and Treatment of Acute Myeloid Leukemia

✍ Lucy A. Godley; John Cunningham; M. Eileen Dolan; R. Stephanie Huang; Sandeep Gu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 785 KB

P-glycoprotein in primary acute myeloid

P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy

✍ Broxterman, H J; Sonneveld, P; van Putten, W J L; Lankelma, J; Eekman, C A; Osse 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Advances in the treatment of acute myelo

Advances in the treatment of acute myeloid leukemia: From chromosomal aberrations to biologically targeted therapy

✍ Michael Lübbert; Carsten Müller-Tidow; Wolf-Karsten Hofmann; H. Phillip Koeffler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract We describe several recent advances in our understanding and treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) including the use of cytogenetics to classify these diseases and to identify therapies that are specific for the abnormalities. Cell lines have provi

Histone deacetylase inhibitors are the p

Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy

✍ Kosugi, H; Towatari, M; Hatano, S; Kitamura, K; Kiyoi, H; Kinoshita, T; Tanimoto 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB

Acute promyelocytic leukemia: a model fo

Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia

✍ Grimwade, D; Lo Coco, F 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 290 KB

Use of the day 6 bone marrow to alter re

Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study

✍ G. Browman; H. Preisler; A. Raza; K. Syracuse; N. Azarnia; A. Benger; P. Cherven 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB